Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Quality of Life in Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease

NCT07659652 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07659652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07659652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Quality of Life in Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
December 31, 2035
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases from breast cancer, breast cancer, metastatic, breast cancer, metastatic breast cancer, breast cancer, quality of life, leptomeningeal metastasis of breast cancer